Jorge Rodriguez

More than just a source of funding—we are a comprehensive platform designed to accelerate success for startups, investors, and emerging venture leaders. Our mission is to empower ambitious founders and aspiring investors by providing access to the tools, knowledge, and community they need to thrive in a competitive market. Through various innovative programs, we help startups scale effectively, teach emerging angels the art of investing, and support venture fellows in building their careers. Our accelerator selects the most promising startups from thousands of applicants annually, offering hands-on mentorship, operational guidance, and access to a robust network of 850+ investors and industry leaders. Meanwhile, our sales program equips founders with critical skills to grow revenue, while our angel and fellow programs are tailored to develop the next generation of investors and venture capital professionals.

Introducing allergens easily and safely for your baby. Our system is simple: a pre-measured, allergist-developed daily packet that mixes in with breast milk, formula, or babys first solid food, containing the top 9 most common childhood food allergies, including peanut, egg, milk, almond, cashew, walnut, soy, wheat, and sesame. 100% organic, non-GMO, and no sugar added.

Glaucoma is the leading cause of blindness and is often related to high intraocular pressure. However, over 10% have progressive visual loss despite optimal intraocular pressure lowering. Our drugs are proven to reduce visual loss in animal studies. Non-human primate studies are pending, and human trials will begin in 2025. Diabetic Retinopathy (DR) is caused by damage to blood vessels in the retina of diabetic patients leading to vision loss. Our DR therapeutics are in the early stages of pre-clinical studies

Discovering new medicines based on metabolic vulnerabilities in pathological cell populations. Underlying platform uses engineered growth conditions to highlight novel metabolic targets in disease-causing bacteria, lymphocytes, and metastasizing cancer cells. Lead programs in autoimmunity and infectious disease.

RealSeq develops groundbreaking RNA fragmentomics technology to allow real-time detection of disease dramatically improving diagnosis and treatment. RiboMarkers are next generation cell free (cf)RNA fragmentomics-based diagnostics that are dynamic reporters able to predict dissemination of disease. We are developing and commercializing a liquid biopsy platform for debilitating fungal pathogens such as Valley Fever that are currently poorly managed yet rapidly increasing due to factors such as climate change with global implications. Our core expertise includes innovative proprietary technologies for bias-free small RNA/miRNA NGS library construction, targeted NGS tools, and cf-RNA analysis (liquid biopsy).

Alleviate makes musculoskeletal pain relief accessible to every body. We design and make self-treatment systems for specific, common, chronic pain pathologies - combining digital and physical technologies and sold direct-to-consumer.

mylittletummyaches.com is a destination for parents navigating their children’s gastrointestinal issues. The forums cover a range of GI topics, from common concerns like constipation and reflux to less common conditions such as eosinophilic esophagitis and abdominal migraines. The site encourages knowledge-sharing among parents, offering resources and emotional support.

More than just a source of funding—we are a comprehensive platform designed to accelerate success for startups, investors, and emerging venture leaders. Our mission is to empower ambitious founders and aspiring investors by providing access to the tools, knowledge, and community they need to thrive in a competitive market. Through various innovative programs, we help startups scale effectively, teach emerging angels the art of investing, and support venture fellows in building their careers. Our accelerator selects the most promising startups from thousands of applicants annually, offering hands-on mentorship, operational guidance, and access to a robust network of 850+ investors and industry leaders. Meanwhile, our sales program equips founders with critical skills to grow revenue, while our angel and fellow programs are tailored to develop the next generation of investors and venture capital professionals.

Introducing allergens easily and safely for your baby. Our system is simple: a pre-measured, allergist-developed daily packet that mixes in with breast milk, formula, or babys first solid food, containing the top 9 most common childhood food allergies, including peanut, egg, milk, almond, cashew, walnut, soy, wheat, and sesame. 100% organic, non-GMO, and no sugar added.

A place for geeks to share what theyve done, who they did it with, the skills they used and connect them with great companies. Since launch (a few months ago), weve attracted tens of thousands of developers ranging from true hackers that are constantly building/creating things every day in open source or for great companies and technology influencers / creators of languages or platforms.